Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148486
Status:
COMPLETED
Last Update Posted:
2013-10-29
First Post:
2005-09-07
Brief Title:
A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinsons Disease Patients Study for Proof of Concept in Early Parkinsons Disease of a Triple Reuptake Inhibitor NS 2330 SCEPTRE
Sponsor:
Organization:
Boehringer Ingelheim